The patient initiated pharmacological treatment for HF, including sacubitril/valsartan, beta-blocker, spironolactone, and sodium-glucose cotransporter-2 (SGLT2) inhibitor, along with furosemide, leading to a gradual resolution of congestive signs and symptoms. This evidence concerns the gene SLC5A2 and hydrops fetalis.